PyrAmes

Executive Summary

PyrAmes is a medical device company developing non-invasive, wireless continuous blood pressure monitoring (cNIBP) solutions for patients across all ages, from neonates to seniors. The company has received FDA clearance for its neonatal platform and is now expanding into adult inpatient and home care settings. By replacing invasive arterial lines and intermittent cuffs with a comfortable, continuous monitoring solution, PyrAmes addresses a critical unmet need in patient monitoring. The technology has the potential to improve outcomes in acute care, reduce alarm fatigue, and enable proactive management of hypertension. With a strong IP portfolio and a clear commercialization roadmap, PyrAmes is well-positioned to capture a significant share of the multi-billion-dollar patient monitoring market. Key risks include competition from established players and the challenge of demonstrating clinical utility in diverse settings.

Upcoming Catalysts (preview)

• Q4 2026FDA clearance for adult inpatient continuous blood pressure monitor65% success
• H2 2026Strategic partnership with a major hospital system or device distributor55% success
• Q3 2026Publication of pivotal clinical study data demonstrating improved outcomes50% success